Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral Blood
Bailón, L., Puertas, M., García-Guerrero, M., Moraes-Cardoso, I., Aparicio, E., Alarcón-Soto, Y.,…Blanco, J., Olvera, A., Mothe, B., Grp, D. S. … Read More